Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?

May 12, 2009

Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. Lansoprazole uncommonly causes chronic watery diarrhea unresponsive to conventional medication as a symptom of collagenous colitis. This association has recently been reported and is not widely known. Correct diagnosis and treatment without this knowledge is impossible. Discontinuation of lansoprazole results in the prompt resolution of diarrhea.

A 70-year old woman developed watery diarrhea 4 to 9 times a day. She had interstitial pneumonia at 67 and reflux esophagitis at 70. Lansoprazole 30 mg/day had been prescribed for reflux esophagitis for nearly 6 months. Lansoprazole was withdrawn due to its possible side effect of diarrhea. Colonoscopy disclosed diffuse cloudiness of the mucosa which suggested ulcerative colitis. Consequently sulfasalazine 2 g/day was started. The patient's diarrhea dramatically disappeared the following day. However, biopsy specimens showed subepithelial collagenous thickening and infiltration of inflammatory cells in the lamina propria confirming the diagnosis of collagenous colitis. One month after sulfasalazine therapy was initiated, both colonoscopic and histological abnormalities resolved completely. Five months later the diarrhea recurred. The findings on colonoscopy and histology were the same as before confirming a diagnosis of collagenous colitis relapse. The author found that the patient had been taking lansoprazole again three months ahead of the recent episode of diarrhea. Withdrawal of lansoprazole promptly resolved the diarrhea. Endoscopic and histological abnormalities were also completely resolved similar to the first episode. Retrospectively, the date of commencement of sulfasalazine and the discontinuation of lansoprazole in the first episode was found to be the same. The author concluded that the patient had lansoprazole-associated collagenous colitis.

This case is reported by Dr. Chiba and his colleagues in the Division of Gastroenterology, Nakadori General Hospital, Akita, Japan and it is to be published on May 7, 2009 in the World Journal of Gastroenterology.

A doctor and a patient can easily recognize the side effects of medication taken recently. However, symptoms occurring in chronic use of a drug such as the present case, diarrhea 6 months after taking lansoprazole, it might be difficult to suspect this side effect. Therefore, knowledge is important: lansoprazole in chronic use can cause chronic diarrhea as a symptom of collagenous colitis.
-end-
Reference: Chiba M, Sugawara T, Tozawa H, Tsuda H, Abe T, Tokairin T, Ono I, Ushiyama E. Lansoprazole-associated collagenous colitis: Diffuse mucosal cloudiness mimicking ulcerative colitis.World J Gastroenterol 2009; 15(17): 2166-2169

http://www.wjgnet.com/1007-9327/15/2166.asp

Correspondence to: Mitsuro Chiba, MD, Division of Gastroenterology, Nakadori General Hospital, 3-15, Misonocho, Minami-dori, Akita 010-8577, Japan. mchiba@meiwakai.or.jp Telephone: +81-18-8331122 Fax: +81-18-8375836

World Journal of Gastroenterology

Related Diarrhea Articles from Brightsurf:

How diarrhea pathogens switch into attack mode at body temperature
Many bacterial pathogens excrete toxins as soon as they have entered the host in order to suppress its immune response.

Scientists link La Niña climate cycle to increased diarrhea
A study in Botswana by Columbia University Mailman School of Public Health scientists finds that spikes in cases of life-threatening diarrhea in young children are associated with La NiƱa climate conditions.

Successful study of Swedish vaccine candidate against diarrhea
University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh.

Rice bran may help curb malnutrition, diarrhea for infants
A new study led by Colorado State University found that adding rice bran for infants who were being weaned from their mother's milk resulted in them receiving more nutrients that enhanced growth and reduced diarrhea.

AGA releases guideline on the evaluation of chronic diarrhea
Diagnosing patients with chronic watery diarrhea can be difficult for health care providers, since several causes with specific therapies, such as inflammatory bowel disease (IBD), microscopic colitis and chronic infection, need to be ruled out.

Fighting child diarrhea
An automatic chlorine dispenser installed at shared community water points reduces rates of diarrhea in children.

Researchers determine bacteria structure responsible for traveler's diarrhea
For the first time researchers have deciphered the near-atomic structure of filaments, called 'pili', that extend from the surface of bacteria that cause traveler's diarrhea.

CFTR inhibition: The key to treating bile acid diarrhea?
Estimates are that roughly 1% of people in Western countries may have bile acid diarrhea, including patients with Crohn's disease, ileal resection, diarrhea-predominant irritable bowel syndrome (IBS-D), and chronic functional diarrhea.

Treatment for common cause of diarrhea more promising
Researchers at Washington University School of Medicine in St. Louis have figured out how to grow the intestinal parasite Cryptosporidium in the lab, an achievement that will speed efforts to treat or prevent diarrhea caused by the parasite.

Widely used public health surveys may underestimate global burden of childhood diarrhea
Public health surveys used in as many as 90 countries may be missing the number of recent diarrhea episodes among children by asking parents and caregivers to recall events two weeks versus one week out, suggests a study from researchers at Johns Hopkins Bloomberg School of Public Health.

Read More: Diarrhea News and Diarrhea Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.